Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Gross Margin: 2009-2025

Historic Gross Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to 31.27%.

  • Lifecore Biomedical's Gross Margin fell 722.00% to 38.37% in Q2 2025 from the same period last year, while for May 2025 it was 31.27%, marking a year-over-year decrease of 136.00%. This contributed to the annual value of 31.27% for FY2025, which is 136.00% down from last year.
  • Lifecore Biomedical's Gross Margin amounted to 31.27% in FY2025, which was down 4.16% from 32.63% recorded in FY2024.
  • Lifecore Biomedical's Gross Margin's 5-year high stood at 38.60% during FY2021, with a 5-year trough of 27.10% in FY2023.
  • Over the past 3 years, Lifecore Biomedical's median Gross Margin value was 31.27% (recorded in 2025), while the average stood at 30.33%.
  • As far as peak fluctuations go, Lifecore Biomedical's Gross Margin surged by 1,399bps in 2021, and later tumbled by 801bps in 2023.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Gross Margin stood at 38.60% in 2021, then tumbled by 349bps to 35.11% in 2022, then plummeted by 801bps to 27.10% in 2023, then surged by 553bps to 32.63% in 2024, then tumbled by 136bps to 31.27% in 2025.